Loading company…
Israel-based developer of urological medical devices, known for the iTind procedure for benign prostatic hyperplasia.
Founded in 2007 and headquartered in Hadera, Israel, Medi-Tate Ltd. develops medical devices for urological conditions. Its iTind procedure is a minimally invasive treatment for benign prostatic hyperplasia that uses a temporary implant, removed after 5 to 7 days. Olympus Corporation acquired the company in February 2021 from Xenia Venture Capital and Laborie, Inc. for USD 300 mn, after the company had closed five deals and raised USD 4 mn in total.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in